Agios Pharmaceuticals (8AP.F) Q3 2025 Earnings

31JulConfirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-1.69
3.84
9.37
14.9

Details

Expected EPS
-1.58260322
Actual EPS
-1.689908
Surprise EPS
-0.11
Surprise Percent
+6.78%

Description

Agios Pharmaceuticals (8AP.F) has reported earnings of -1.689908 per share for Q3 2025.

0 Comments

Share your thoughts